Senzime AB (OSTO:SEZI)
kr 7.53 0.42 (5.91%) Market Cap: 901.38 Mil Enterprise Value: 795.75 Mil PE Ratio: 0 PB Ratio: 2.55 GF Score: 70/100

Q3 2023 Senzime AB (publ) Earnings Call Transcript

Oct 26, 2023 / 06:00AM GMT
Release Date Price: kr6.52 (+4.32%)
Klas Palin
Erik Penser Bank - Analyst

Good morning, everyone. Welcome to Erik Penser Bank, this morning's slide presentation of the nine months interim report of Senzime. And here to present the nine month report is CEO, Philip Siberg, very welcome.

Philip Siberg;publ;CEO
Senzime AB

()-

Good morning.

Klas Palin
Erik Penser Bank - Analyst

Go ahead with your presentation, please.

Philip Siberg;publ;CEO
Senzime AB

()-

All right. Thank you, thank you very much. I'm here to kind of give the highlights of the Q3 report that we just published this morning here in Sweden.

So Senzime, just a brief recap. We are a Swedish headquartered medical device company. We're in the midst of a technology and clinical shift where we are providing monitoring solutions to help eliminate complications as a result of anesthesia and also as a result of opioids and other medications as you're in the perioperative mode of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot